Seguimiento a lo largo plazo de marcadores analíticos y radiológicos de los pacientes diabéticos con sospecha clínica de osteomielitis tras el cierre completo de su lesión
Loading...
Download
Official URL
Full text at PDC
Publication date
2020
Defense date
08/07/2020
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citation
Abstract
La osteomielitis de Pie Diabético representa aproximadamente el 50,0% delas infecciones de las úlceras de Pie Diabético, siendo la primera causa de amputación menor y mayor de los pacientes afectados. La amputación mayor en pacientes diabéticos se asocia a elevados costes sociosanitarios ya una tasa de mortalidad a los 2 y 5 años del 48,0% y del 68,0%,respectivamente. En la actualidad, no existe un consenso sobre los criterios diagnósticos de la osteomielitis de Pie Diabético y esto en ocasiones se traduce en un retraso terapéutico. De igual manera, la ausencia de indicadores diagnósticos y evolutivos de la osteomielitis de Pie Diabético no permite evaluar con claridad la ventaja terapéutica del tratamiento quirúrgico frente al médico. Además, aún no se han definido unos criterios claros acerca de la curación de la osteomielitis de Pie Diabético, que permitirían definir indicadores de evolución y resolución basados en marcadores analíticos y radiológicos, facilitando el tratamiento y el seguimiento de esta enfermedad, reduciendo los costes de tratamiento, las amputaciones y las tasas de mortalidad...
Diabetic foot osteomyelitis represents approximately 50.0% of all diabetic foot ulcers infections, being the primary cause of minor and mayor amputations for patients. Mayor amputations in diabetic foot patients are associated with higher healthcare costs and mortality rates, 48.0% and68.0% at 2 and 5 years’ time, respectively. Currently, there is no consensus regarding diabetic foot osteomyelitis diagnosis criteria, occasionally resulting in therapeutic delay. Similarly, the lack of diabetic foot osteomyelitis diagnosis and evolution markers hinders the assessment of therapeutical advantages of medical versus surgical treatments. In addition, clear criteria about the cure of diabetic foot osteomyelitis are yet to be defined what would permit, in turn, to establish evolution and resolution indicators based on analytical and radiological markers. Furthermore, the establishment of clear cure criteria would facilitate the treatment and follow-up of this disease, reducing treatment costs, amputations and mortality rates
Diabetic foot osteomyelitis represents approximately 50.0% of all diabetic foot ulcers infections, being the primary cause of minor and mayor amputations for patients. Mayor amputations in diabetic foot patients are associated with higher healthcare costs and mortality rates, 48.0% and68.0% at 2 and 5 years’ time, respectively. Currently, there is no consensus regarding diabetic foot osteomyelitis diagnosis criteria, occasionally resulting in therapeutic delay. Similarly, the lack of diabetic foot osteomyelitis diagnosis and evolution markers hinders the assessment of therapeutical advantages of medical versus surgical treatments. In addition, clear criteria about the cure of diabetic foot osteomyelitis are yet to be defined what would permit, in turn, to establish evolution and resolution indicators based on analytical and radiological markers. Furthermore, the establishment of clear cure criteria would facilitate the treatment and follow-up of this disease, reducing treatment costs, amputations and mortality rates
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Enfermería, Fisioterapia y Podología, leída el 08-07-2020